PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma

Results confirm that FOLFIRINOX improves PFS significantly compared with gemcitabine and is well tolerated in LAPC. No significant difference in OS was observed between both groups.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-16
DOI
https://doi.org/10.1200/jco-24-02210
Citations
19
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
19.86
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma

Olivier Capitain, Marion Bolliet, Frédéric Di Fiore, Anne-Laure Bignon et al.
19 citations
Journal of Clinical Oncology
Pancreatic and Hepatic Oncology Research
19.86
article

PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma

Olivier Capitain, Marion Bolliet, Frédéric Di Fiore, Anne-Laure Bignon, Valérie Lebrun-Ly, Ludovic Evesque, Matthieu Texier, Aurélie Parzy, Pierre-Luc Etienne, Jean‐Baptiste Bachet, Pierre Vanelslander, Farid El Hajbi, Nicolas De Sousa Carvalho, Olivier Bouché, Thierry Lecomte, Michel Ducreux, Yves Rinaldi, Rosine Guimbaud, Julien Forestier, Romain Desgrippes
article en
19 citations

Abstract

Results confirm that FOLFIRINOX improves PFS significantly compared with gemcitabine and is well tolerated in LAPC. No significant difference in OS was observed between both groups.

Journal of Clinical OncologyVol. 43(20)
Inserm (FR), Université Paris-Saclay (FR), Institut Gustave Roussy (FR), Sorbonne Université (FR), Hôpital Charles-Nicolle (FR), Hopitaux Civils de Colmar (FR), Centre Hospitalier Universitaire de Tours (FR), Assistance Publique – Hôpitaux de Paris (FR), Centre Hospitalier Universitaire de Reims (FR), Institut de Cancérologie de l'Ouest (FR), Hôpital Européen (FR), Centre Hospitalier Universitaire de Caen Normandie (FR), Centre Hospitalier de Saint-Malo (FR), Centre Hospitalier Universitaire de Limoges (FR), Centre François Baclesse (FR), Hôpital Rangueil (FR), Hôpital Edouard Herriot (FR), Centre Oscar Lambret (FR), UniCancer Group (FR), Centre Antoine Lacassagne (FR), Université de Reims Champagne-Ardenne (FR)
Good health and well-being
Openalex Percentile: Top 1%
Pancreatic and Hepatic Oncology Research
19.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.